Literature DB >> 29974630

Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta-Analysis and Systematic Review.

Salehoddin Bouya1, Abbas Balouchi2,3, Hosein Rafiemanesh4,5, Mehran Hesaraki6.   

Abstract

The aim of this study was to determine the prevalence of CKD in the Iranian general population. In this systematic review and meta-analysis study, international (PubMed, Web of Science, Scopus, and Google scholar) and national databases (SID, Magiran) were searched until December 30, 2017. The quality of the studies was evaluated using the Hoy instrument. Out of 1170 initial studies, 9 studies with a total of 70 605 participants were included in the final stage of this study. Based on the results of the random effect method (95% CI), the overall prevalence of chronic kidney disease in 70 605 people was 15.14% (I2  = 99.77%). The prevalence of CKD in female patients (18.80%) was 1.7 times higher than in male patients (10.83). The results of the present study indicate a higher than the global average prevalence of CKD in Iran and the need for additional attention of policy makers on better planning for control and implementation of screening programs in high-risk populations, such as patients with hypertension and diabetes.
© 2018 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Iran; Prevalence; Renal failure; Systematic review

Mesh:

Year:  2018        PMID: 29974630     DOI: 10.1111/1744-9987.12716

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  8 in total

1.  Prediction of Mortality Incidence in Patients with Chronic Kidney Disease Based on Influential Prognostic Factors with Competing Risks Approach.

Authors:  Anahita Saeedi; Ahmadreza Baghestani; Seyed-Saeed Hashemi-Nazari; Farzanehsadat Minoo; Navid Mohseni; Zahra Esfahani
Journal:  Galen Med J       Date:  2020-12-18

2.  The diagnostic efficacy of diffusion tensor imaging generated by gadolinium-based magnetic resonance imaging for patients with chronic kidney disease.

Authors:  Liu He; Gao Dan; Sun Yuanbo; Tang Fengqiong; Hu Mingcheng; Hongyi Li
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

3.  Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver.

Authors:  Sima Golmohammadi; Marjan Tavasoli; Nadia Asadi
Journal:  Clin Exp Gastroenterol       Date:  2020-08-20

4.  Prevalence of impaired renal function and determinants in the southwest of Iran.

Authors:  Saba Alvand; Farhad Abolnezhadian; Sudabeh Alatab; Zahra Mohammadi; Fatemeh Hayati; Mohammad Noori; Leila Danehchin; Yousef Paridar; Bahman Cheraghian; Zahra Rahimi; Sanam Hariri; Sahar Masoudi; Seyed Ali Mard; Ali Akbar Shayesteh; Hossein Poustchi
Journal:  BMC Nephrol       Date:  2021-08-10       Impact factor: 2.388

5.  Association of Vegetarian Diet with Chronic Kidney Disease.

Authors:  Hao-Wen Liu; Wen-Hsin Tsai; Jia-Sin Liu; Ko-Lin Kuo
Journal:  Nutrients       Date:  2019-01-27       Impact factor: 5.717

6.  Association between nutritional, inflammatory and oxidative status (NIOS) and risk of adverse outcomes in patients on haemodialysis (HD): the NIOS-HD prospective cohort study protocol.

Authors:  Sahar Foshati; Gholamreza Askari; Mohammad Bagherniya; Mojgan Mortazavi; Firouzeh Moeinzadeh; Shahram Taheri; Zahra Heidari; Mohammad Hossein Rouhani
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

7.  Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease in a Population-based Study: Tehran Thyroid Study.

Authors:  Sara Kazempour-Ardebili; Atefeh Amouzegar; Maryam Tohidi; Atieh Amouzegar; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2021-03-17

8.  Dietary Patterns and Risk of Chronic Kidney Disease Among Tehranian Adults with High Blood Pressure.

Authors:  Niloofar Naderinejad; Hanieh-Sadat Ejtahed; Golaleh Asghari; Parvin Mirmiran; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2020-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.